Other functions: production of adenoviral vector vaccines
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN272200550015C
- Awardee
-
Janssen Vaccines & Prevention B.V. UEI VRE2EKNJTJJ4
- Awarding agency
-
NIAID DEA OA Acquisitions
National Institutes of Health, Department of Health and Human Services
- Obligated
- $13,003,542
Award facts
- Contract value 17% obligated
-
- $26,804,541.85 Current, with exercised options
- $77,606,315.85 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Netherlands
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$5,199,858 | |
| Other Administrative Action | -$3,143,600 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $3,110,000 | |
| Supplemental Agreement for work within scope | $420,000 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $1,355,000 | |
| Supplemental Agreement for work within scope | $117,000 | |
| Supplemental Agreement for work within scope | $198,000 | |
| Supplemental Agreement for work within scope | $4,700,000 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $0 | |
| Supplemental Agreement for work within scope | $3,700,000 | |
| Supplemental Agreement for work within scope | $500,000 | |
| Supplemental Agreement for work within scope | $2,700,000 | |
| Other Administrative Action | $385,000 | |
| Funding Only Action | $2,010,000 | |
| Original award | $2,152,000 |
Show all 19
About this award
This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Janssen Vaccines & Prevention B.V., a foreign-owned for-profit organization, to produce adenoviral vector vaccines containing Ebola inserts. The contract has a ceiling value of $77,606,315.85 and was awarded on April 13, 2005, with an ultimate completion date of August 8, 2012. The contract type is a Definitive Contract with a Cost Plus Fixed Fee pricing type. The place of performance is in the Netherlands, and there was no set-aside used for this award.
Quick answers
Who was awarded contract HHSN272200550015C?
HHSN272200550015C was awarded to Janssen Vaccines & Prevention B.V. by NIAID DEA OA Acquisitions (National Institutes of Health) on April 13, 2005.
How much is contract HHSN272200550015C worth?
The government has obligated $13,003,542 on HHSN272200550015C. Its current value, with exercised options, is $26,804,542. Its potential value, with all options, is $77,606,316.
Was contract HHSN272200550015C competed?
The extent of competition for HHSN272200550015C was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award